Vanguard Group Inc Clear Point Neuro, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,475,120 shares of CLPT stock, worth $15.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,475,120

Previous 1,283,978 14.89%

Holding current value

$15.4 Million

Previous $15.3 Million 15.37%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$10.51 - $14.71 $2.01 Million - $2.81 Million	191,142 Added 14.89%	1,475,120 $17.6 Million
Q1 2025 May 09, 2025	BUY	$11.89 - $18.8 $423,105 - $668,998	35,585 Added 2.85%	1,283,978 $15.3 Million
Q4 2024 Feb 11, 2025	BUY	$10.74 - $16.68 $57,996 - $90,072	5,400 Added 0.43%	1,248,393 $19.2 Million
Q3 2024 Nov 13, 2024	BUY	$5.3 - $13.18 $141,123 - $350,943	26,627 Added 2.19%	1,242,993 $13.9 Million
Q2 2024 Aug 13, 2024	SELL	$5.25 - $6.73 $479,498 - $614,671	-91,333 Reduced 6.98%	1,216,366 $6.56 Million
Q1 2024 May 10, 2024	SELL	$6.03 - $7.86 $5,999 - $7,820	-995 Reduced 0.08%	1,307,699 $8.89 Million
Q4 2023 Feb 14, 2024	BUY	$4.46 - $7.07 $149,026 - $236,236	33,414 Added 2.62%	1,308,694 $8.89 Million
Q3 2023 Nov 14, 2023	BUY	$5.01 - $7.09 $279,477 - $395,508	55,784 Added 4.57%	1,275,280 $6.39 Million
Q2 2023 Aug 14, 2023	BUY	$6.54 - $10.58 $821,862 - $1.33 Million	125,667 Added 11.49%	1,219,496 $8.83 Million
Q1 2023 May 15, 2023	BUY	$7.33 - $10.63 $531,329 - $770,536	72,487 Added 7.1%	1,093,829 $9.23 Million
Q4 2022 Feb 10, 2023	BUY	$7.7 - $11.21 $257,749 - $375,243	33,474 Added 3.39%	1,021,342 $8.65 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $16.49 $76,654 - $128,720	7,806 Added 0.8%	987,868 $10.2 Million
Q2 2022 Aug 12, 2022	SELL	$7.09 - $13.65 $713,211 - $1.37 Million	-100,594 Reduced 9.31%	980,062 $12.8 Million
Q1 2022 May 13, 2022	BUY	$7.8 - $11.6 $1.21 Million - $1.8 Million	154,867 Added 16.73%	1,080,656 $11.2 Million
Q4 2021 Feb 14, 2022	BUY	$11.08 - $18.86 $712,621 - $1.21 Million	64,316 Added 7.47%	925,789 $10.4 Million
Q3 2021 Nov 12, 2021	BUY	$16.58 - $22.25 $637,318 - $855,267	38,439 Added 4.67%	861,473 $15.3 Million
Q2 2021 Aug 13, 2021	BUY	$17.23 - $22.77 $14.2 Million - $18.7 Million	823,034 New	823,034 $15.7 Million

Others Institutions Holding CLPT

# of Institutions

101

Shares Held

7.91M

Call Options Held

116K

Put Options Held

46.8K

View Full List

About ClearPoint Neuro, Inc.

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $256M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

More about CLPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Clear Point Neuro, Inc. Transaction History